Alembic Pharmaceuticals Ltd (APLLTD) Stock Price & News

APLLTD:NSE

Alembic Pharmaceuticals Ltd

₹789.35

-1.07%

(-8.50) 1D

Nov 2, 10:57:03 AM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Next call in 2 days

Wed, Nov 4, 1:30 PM

Fiscal period

Q2 2027

- / ₹10.97

Revenue / Est. (INR)

- / 23.34B

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	19.10B	18.76B	18.48B	21.50B
Cost of goods sold	5.16B	5.29B	6.27B	6.20B
Cost of revenue	5.16B	5.29B	6.27B	6.20B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.38B	4.33B	4.39B	4.74B
Operating expense	11.55B	11.34B	10.85B	12.96B
Total operating expenses	16.71B	16.63B	17.11B	19.16B
Operating income	2.40B	2.13B	1.36B	2.34B
Other non operating income	69.00M	154.90M	-285.60M	149.30M
EBT including unusual items	2.24B	1.61B	1.19B	2.22B
EBT excluding unusual items	2.24B	2.04B	1.37B	2.22B
Income tax expense	400.00M	295.40M	-829.00M	495.00M
Effective tax rate	17.88%	18.29%	-69.88%	22.31%
Other operating expenses	6.41B	6.21B	5.56B	7.24B
Net income	1.85B	1.33B	2.03B	1.73B
Net profit margin	9.67%	7.09%	10.97%	8.05%
Earnings per share	9.40	8.51	11.57	8.80
Interest and investment income	-	-	8.60M	-
Interest expense	-242.30M	-233.10M	-225.60M	-276.10M
Net interest expenses	-242.30M	-233.10M	-217.00M	-276.10M
Depreciation and amortization charges	760.70M	801.20M	885.90M	977.10M
EBITDA	3.15B	2.78B	2.12B	3.09B
Gain or loss from assets sale	-	-	-	-

Finance